Validation of the Scandinavian Guidelines for Minor and Moderate Head Trauma in Children
SHIPP
A Pragmatic, Prospective, Multicentre Study for the Validation of the Scandinavian Guidelines for Minor and Moderate Head Trauma in Children
1 other identifier
observational
5,300
2 countries
16
Brief Summary
Head injuries are common among children and adolescents, with many of them assessed in emergency departments each year. Most children recover fast, with full resolution of symptoms as headache, dizziness or fatigue. A few, however, develop life-threatening complications (such as bleedings in/around the brain). It can be difficult to swiftly and accurately identify these patients in the emergency department. To aid in this task, decision support tools has been developed. The goal of this observational study is to evaluate a Scandinavian tool developed to aid in management of children with head injuries seeking care in an emergency department. The main research question is: \- Are the Scandinavian guidelines for management of mild and moderate head trauma in children sensitive for patient-important outcomes? Patients will be given the same treatment and recommendations for their head injury no matter if they participate or not in the study, as there is no intervention/ treatment group. The doctor or nurse managing the child will collect information on patient history, signs and symptoms in the emergency department and management in an electronic case report form. Information on how the recovery period is collected both from medical records \>1 month after the emergency department visit, as well as via electronic questionnaires sent to the guardian at 1 month, 3 months and 4 months after the injury via e-mail and/or text message. Long-term outcome will also be examined (\>6 months).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2018
Longer than P75 for all trials
16 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2018
CompletedFirst Submitted
Initial submission to the registry
June 22, 2023
CompletedFirst Posted
Study publicly available on registry
July 28, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2029
ExpectedFebruary 28, 2024
February 1, 2024
6.4 years
June 22, 2023
February 27, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Number of participants with "clinically important intracranial injury (CIII)"
Defined as a composite variable of death, neurosurgery, admission to hospital ward two (2) days or more due to head injury or intubation one (1) day or more due to pathological traumatic CT findings.
Within 1 week of injury.
Secondary Outcomes (24)
Number of participants with death due to head injury
Within one week; within 3 months.
Number of participants with neurosurgery due to TBI
Within 1 week of injury.
Number of participants with CT findings
Within 1 week of injury.
Number of participants with significant CT findings
Within 1 week of injury.
Concentration of specific biomarkers in serum and saliva
Sampling at admission to the emergency department
- +19 more secondary outcomes
Other Outcomes (4)
Participant rating on GOS-E PEDS Score
3 months after injury
Participant rating on Post Concussion Symptom Inventory - Parent (PCSI-P) assessment
3 months after injury.
Participant rating on Mental Fatigue Scale
1 month and 4 months after injury.
- +1 more other outcomes
Eligibility Criteria
Target population is children in Scandinavia with recent minor and moderate head trauma seeking care on emergency departments within participating in study.
You may qualify if:
- Age \<18 years.
- Minor and moderate blunt head trauma (GCS 9 - 15) seeking medical assessment in an emergency department at a study hospital in Sweden or Norway.
- Within 24 hours of trauma.
- Informed oral consent from one guardian, and child if older than 14 years old, after receiving oral and written information about study.
You may not qualify if:
- Patient and/or guardian does not wish to participate in the study.
- Patient included in other study that may affect the management/treatment in the emergency department.
- Penetrating head injury (as those will always receive a CT scan).
- Suspected child abuse / non-accidental trauma (NAT) denoted as suspected child abuse where the social services are informed (as they will always receive a CT scan).
- The patient is not a citizen in the participating country and hence difficult to follow up.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (16)
Haukeland Universitetssjukehus
Haukeland, Norway
Alingsås Lasarett
Alingsås, Sweden
Mälarsjukhuset i Eskilsstuna
Eskilstuna, Sweden
Drottning Silvias Barnsjukhus
Gothenburg, Sweden
Halland Hospital Halmstad
Halmstad, Sweden
Länssjukhuset Ryhov
Jönköping, Sweden
Lasarettet i Ljungby
Ljungby, Sweden
Skåne University Hospital, Lund
Lund, Sweden
Skånes Universitetssjukhus Malmö
Malmo, Sweden
Mora Lasarett
Mora, Sweden
Örebro Universitetssjukhus
Örebro, Sweden
Astrid Lindgren Childrens Hospital, Solna
Stockholm, Sweden
Norra Älvsborgs Länssjukhus
Trollhättan, Sweden
Norrland University Hospital, NUS
Umeå, Sweden
Halland Hospital Varberg
Varberg, Sweden
Ystad Lasarett
Ystad, Sweden
Related Publications (2)
Wickbom F, Thornberg S, Sotoca Fernandez J, Silfver R, Marklund N, Unden J; Scandinavian Neurotrauma Committee. Comparison of predictive tools for management of paediatric mild TBI: a prospective cohort study. EClinicalMedicine. 2025 Sep 9;88:103484. doi: 10.1016/j.eclinm.2025.103484. eCollection 2025 Oct.
PMID: 40979218DERIVEDWickbom F, Calcagnile O, Marklund N, Unden J. Validation of the Scandinavian guidelines for minor and moderate head trauma in children: protocol for a pragmatic, prospective, observational, multicentre cohort study. BMJ Open. 2024 Apr 3;14(4):e078622. doi: 10.1136/bmjopen-2023-078622.
PMID: 38569695DERIVED
Related Links
Biospecimen
In a subgroup of patients (target n=1000) a blood and saliva sample for postponed analysis of biomarkers in TBI will be obtained after written informed consent.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Johan Undén, MD, PhD.
Region Halland and Lund University, Sweden
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 4 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 22, 2023
First Posted
July 28, 2023
Study Start
April 1, 2018
Primary Completion
August 31, 2024
Study Completion (Estimated)
December 31, 2029
Last Updated
February 28, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
- Time Frame
- Data will be available on reasonable request up to 10 years after study completion.
- Access Criteria
- Investigators whose proposed use of the data has been approved by the study review committee and sharing of requested data is permitted by Swedish and European law.
Sharing of de-identified data for all primary and secondary outcome measures will be considered on individual basis after main and secondary analysis has been completed.